Sectoral Asset Management Inc Eye Point Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$19.93 - $29.71 $222,817 - $332,157	11,180 Added 13.78%	92,340 $1.91 Million
Q4 2023 Feb 14, 2024	SELL	$5.71 - $24.13 $541,993 - $2.29 Million	-94,920 Reduced 53.91%	81,160 $1.88 Million
Q3 2023 Nov 14, 2023	SELL	$7.99 - $15.36 $1.08 Million - $2.08 Million	-135,197 Reduced 43.43%	176,080 $1.41 Million
Q2 2023 Aug 11, 2023	BUY	$3.03 - $9.0 $943,169 - $2.8 Million	311,277 New	311,277 $2.71 Million

153

58.2M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $294M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.